$Palantir Technologies Inc.(PLTR)$ Consider its strong AI software position, commercial growth, and potential government contracts, it should be a good buy despite its high valuation and uncertainty. Dyodd.
$UnitedHealth(UNH)$ UnitedHealth Group (UNH) stock has taken a hit after HSBC downgraded it to "reduce" with a target price of $270, down from $490. Additionally, Wolfe Research cut its price target to $390 with an "outperform" rating. The stock's current price is around $302.98, and it's down 5.78% with a previous close of $321.58. Ultimately, whether it's time to buy UNH stock at $295 depends on your individual investment goals, risk tolerance, and analysis of the company's fundamentals. Can consider dollar-cost averaging if the price drops further, and hold on for the next bull run. Dyodd.
$UMS(558.SI)$ Stock shows bullish signs, with positive chart pattern, bullish analyst sentiment from Maybank and DBS as well as strong revenue growth and net profit increase. Time to go to the moon π
$UnitedHealth(UNH)$ Stock fell 3.4% after strong Q1 results. If considering buying the dip, weigh factors like company performance, valuation, regulatory risks, and market conditions. I see the potential to buy some. π
Crypto currencies are highly speculative and lack fundamental value. In contrast, equities have inherent value and potential for long-term growth. It's often wiser to hold onto equity rather than selling it, especially during market fluctuations.
$LION OCBC HSTECH ETF S$(HST.SI)$ The overall market sentiment has shifted positively, with investors becoming more optimistic about the tech sector's growth prospects. πππ
Analysts have issued a consensus "Moderate Buy" rating for Bilibili, with a price target of $19.69, suggesting potential downside risk. While resuming $30 is uncertain, the current momentum and positive earnings report indicate a potential upward trend. To make a more accurate prediction, it's essential to monitor market fluctuations and analyst forecasts closely.